Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Single-Center, Dose Escalation Study of D2C7-IT Administered Intratumorally Via Convection-Enhanced Delivery for Adult Patients With Recurrent Malignant Glioma

NCT02303678 is registered in ClinicalTrials.gov with Darell Bigner as lead sponsor.

NCT NCT02303678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Single-Center, Dose Escalation Study of D2C7-IT Administered Intratumorally Via Convection-Enhanced Delivery for Adult Patients With Recurrent Malignant Glioma
Lead sponsor
Darell Bigner
Phase
Phase 1
Overall status
Completed
Start date
May 5, 2015
Completion date
March 25, 2024
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, malignant glioma